Latest News and Press Releases

Payment of the interests of the Highbridge/Whitebox loans Information on the total number of voting rights (denominator) Liege, Belgium, 12 May 2023 – 17:50 CET – Mithra Pharmaceuticals SA...

Mithra Announces Completion of Recruitment in Pediatric Study of Estelle in Adolescent Patients Trial designed to address limited clinical data in this population despite widespread use of Combined...

Collaboration demonstrates Mithra’s commitment to innovation and sustainable drug supply in Women’s Health Liege, Belgium, 04 May 2023 – 7:30 CEST – Mithra (Euronext Brussels: MITRA), a company...

Liege, Belgium, 28 April 2023 – 17:45 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007...

Mithra Releases Invitation to its General Shareholders’ Meeting Liege, Belgium, 25 April 2023 – 7:30 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces...

Record revenue (EUR 96.5 million) and EBITDA (EUR 40.7 million) increased respectively by 47% and 6%, mainly driven by U.S. deal for Estelle®Anticipated future licensing milestones for Estelle®...

Estelle® to be the 1st Combined Oral Contraceptive (COC) based on an environmental friendly estrogen (E4)Environmental Risk Assessment study demonstrates absence of environmental risk for Estetrol...

Historical agreement with Mayne Pharma, who became the second largest supplier of oral contraceptives in the US after the acquisition of a portfolio of branded generic products from TEVA in...

Mithra annonce ses résultats annuels 2018 Forte croissance du chiffre d'affaires (+42%) et amélioration significative de l'EBITDA qui atteint un niveau record (38,3 millions EUR contre -18,4...

Mithra Reports 2018 Annual Results Strong revenue growth (+42%) with significantly improved EBITDA (record level of EUR 38.3 M vs. EUR -18.4 M in 2017) and cash position (EUR 119 M vs. EUR 36.2 M...